Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes

Neuropsychopharmacology

Volumn 27, Issue 5, 2002, Pages 756-764

  Husum, Henriette ^a,b   Mathé, Aleksander A ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Rigshospitalet   (Denmark)

Author keywords

Corticosterone; CRH; Lithium; Maternal deprivation; NPY; Rat; Stress

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; LITHIUM SULFATE; NEUROPEPTIDE Y;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOSTERONE BLOOD LEVEL; DIETARY INTAKE; DRUG EFFECT; FEMALE; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOREACTIVITY; MALE; MATERNAL DEPRIVATION; MENTAL STRESS; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; FEMALE; LITHIUM COMPOUNDS; MALE; MATERNAL DEPRIVATION; NEUROPEPTIDE Y; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; STRESS; SULFATES;

EID: 0036848459     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00363-9     Document Type: Article

References (70)

1. Agid O., Shapira B., Zislin J., Ritsner M., Hanin B., Murad H., Troudart T., Bloch M., Heresco-Levy U., Lerer B. Environment and vulnerability to major psychiatric illness. a case control study of early parental loss in major depression, bipolar disorder and schizophrenia Mol Psychiatry. 4:1999;163-172.
2. Albers H.E., Ottenweller J.E., Liou S.Y., Lumpkin M.D., Anderson E.R. Neuropeptide Y in the hypothalamus. effect on corticosterone and single-unit activity Am J Physiol. 258:1990;R376-R382.
3. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol. 160:1999;1-12.
4. Baastrup P.C., Poulsen J.C., Schou M., Thomsen K., Amdisen A. Prophylactic lithium. double blind discontinuation in manic- depressive and recurrent-depressive disorders Lancet. 2:1970;326-330.
5. Corder R., Pralong F.P., Turnill D., Saudan P., Mullar A.F., Gaillard R.C. Dexamethasone treatment increases neuropeptide Y mRNA levels in the hypothalamic neurones. Life Sci. 43:1988;1879-1886.
6. Ehlers C.L., Li T.K., Lumeng L., Hwang B.H., Somes C., Jiménez P.A., Mathé A.A. Neuropeptide Y levels in ethanol-naive alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure. Alcohol Clin Exp Res. 22:1998;1778-1782.
7. Ehlers C.L., Somes C., Seifritz E., Rivier J.E. CRF/NPY interactions. a potential role in sleep dysregulation in depression and anxiety Depress Anxiety. 6:1997;1-9.
8. Gage F.H. Mammalian neural stem cells. Science. 287:2000;1433-1438.
9. Ghosh D., Biswas N.M., Ghosh P.K. Effect of lithium chloride on adrenocortical activity in male rats. evidence of dose and duration dependent response Indian J Physiol Pharmacol. 34:1990;263-266.
10. Gjerris A., Widerlöv E., Werdelin L., Ekman R. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J Psychiatry Neurosci. 17:1992;23-27.
11. Gould E., Cameron H.A., Daniels D.C., Wooley C.S., McEwen B.S. Adrenal hormones suppress cell division in the adult rat dentate gyrus. J Neurosci. 12:1992;3642-3650.
12. Gruber S.H., Mathé A.A. Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum. J Neurosci Res. 61:2000;458-463.
13. Haas D.A., George S.R. Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity. lack of effect in other rat brain regions Life Sci. 41:1987;2725-2731.
14. Hansel D.E., Eipper B.A., Ronnett G.V. Neuropeptide Y functions as a neuroproliferative factor. Nature. 410:2001;940-944.
15. Heilig M., Ekman R. Chronic parenteral antidepressant treatment in rats. unaltered levels and processing of neuropeptide Y (NPY) and corticotropin- releasing hormone (CRH) Neurochem Int. 26:1995;351-355.
16. Heilig M., Koob G., Ekman R., Britton K.T. Corticotropin-releasing factor and neuropeptide Y. role in emotional integration Trends Neurosci. 17:1994;80-85.
17. Heinrichs S.C., Menzaghi F., Pich E.M., Koob G.F. Corticotropin-releasing factor in paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res. 611:1993;18-24.
18. Holmes P.V., Davis R.C., Masini C.V., Primeaux S.D. Effects of olfactory bulbectomy on neuropeptide gene expression in the rat olfactory/limbic system. Neuroscience. 86:1998;587-596.
19. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 23:2000;477-501.
20. Husum H., Jiménez Vasquez P.A., Mathé A.A. Changed concentrations of tachykinins and neuropeptide Y in brain of a rat model of depression. Lithium treatment normalizes tachykinins. Neuropsychopharmacology. 24:2001;183-191.
21. Husum H., Termeer E., Mathé A.A., Boludi G.T.G., Ellenbroek B.A. Early maternal deprivation alters hippocampal levels of neuropeptide Y and calcitonin-gene related peptide in adult rats. Neuropharmacology. 42:2002;798-806.
22. Husum H., Mikkelsen J.D., Hogg S., Mathé A.A., Mørk A. Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram. Neuropharmacology. 39:2000;1463-1473.
23. Jacobs B.L., Praag H., Gage F.H. Adult brain neurogenesis and psychiatry. a novel theory of depression Mol Psychiatry. 5:2000;262-269.
24. Jiménez Vasquez P.A., Mathé A.A., Thomas J.D., Riley E.P., Ehlers C.L. Early maternal separation alters neuropeptide Y concentrations in selected brain regions in adult rats. Brain Res Dev Brain Res. 131:2001;149-152.
25. Jiménez Vasquez P.A., Overstreet D.H., Mathé A.A. Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli. J Psychiatr Res. 34:2000;405-412.
26. Kalin N.H., Carnes M. Biological correlates of attachment bound disruption in humans and nonhuman primates. Prog Neuropsychopharmacol Biol Psychiatry. 8:1984;459-469.
27. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., Eaves L.J. Childhood parental loss and adult psychopathology in women. A twin study perspective. Arch Gen Psychiatry. 49:1992;109-116.
28. Ladd C.O., Owens M.J., Nemeroff C.B. Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology. 137:1996;1212-1218.
29. Larsen P.J., Jessop D.S., Chowdrey H.S., Lightman S.L., Mikkelsen J.D. Chronic administration of glucocorticoids directly upregulates preproNeuropeptide Y and Y1 receptor mRNA levels in the arcuate nucleus of the rat. J Neuroendocrinol. 6:1994;153-159.
30. Leibowitz S.F., Sladek C., Spencer L., Tennant C. Neuropeptide Y, epinephrine and norepinephrine in the paracentricular nucleus. stimulation of feeding, and the release of corticosterone, vasopressin and glucose Brain Res Bull. 21:1988;905-912.
31. Lenox R.H., Manji H.K. Lithium. Schatzberg A.F., Nemeroff C.B. Textbook of Psychopharmacology. 1998;379-429 American Psychiatric Press, Inc. Washington, DC.
32. Lindefors N., Brené S., Herrara-Marschitz M., Persson H. Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons. Exp Brain Res. 80:1990;489-500.
33. Linton E.A., Lowry P.J. Comparison of a specific two-site immunoradiometric assay with radioimmunoassay for rat/human CRF-41. Regul Pept. 14:1986;69-84.
34. Liposits Z., Sievers L., Paull W.K. Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat. An immunocytochemical analysis at the light and electron microscopic levels. Histochemistry. 88:1988;227-234.
35. Liu D., Diorio J., Tannenbaum B., Caldji C., Francis D.D., Freedman A., Sharma S., Pearson D., Plotsky P.M., Meaney M.J. Maternal care, hippocampal glucocorticoid receptors and hypothalamic-pituitary-adrenal responses to stress. Science. 277:1997;1659-1662.
36. Maeda K., Kawata E., Sakai T., Chihara K. Effects of putative cognitive function-enhancing drugs and dopaminergic agents on somatostatin and neuropeptide Y in rat brain. Eur J Pharmacol. 233:1993;227-235.
37. Makino S., Baker R.A., Smith M.A., Gold P.W. Differential regulation of neuropeptide Y mRNA expression in the arcuate nucleus and locus coeruleus by stress and antidepressants. J Neuroendocrinol. 12:2000;387-395.
38. Mathé A.A. Neuropeptides and electroconvulsive treatment. J ECT. 15:1999;60-75.
39. Mathé A.A., Gruber S., Jiménez P.A., Theodorsson E., Stenfors C. Effects of electroconvulsive stimuli and MK-801 on neuropeptide Y, neurokinin A, and calcitonin gene-related peptide in rat brain. Neurochem Res. 22:1997;629-636.
40. Mathé A.A., Jiménez P.A., Theodorsson E., Stenfors C. Neuropeptide Y, Neurokinin A and neurotensin in brain regions of Fawn Hooded "depressed", Wistar and Sprague Dawley rats. Effects of electroconvulsive stimuli. Prog Neuropsychopharmacol Biol Psychiatry. 22:1998;529-546.
41. Mathé A.A., Rudorfer M.V., Stenfors C., Manji H.K., Potter W.Z., Theodorsson E. Effects of electroconvulsive treatment on somatostatin, neuropeptide Y, endothelin, and neurokinin A concentrations in cerebrospinal fluid of depressed patients. A pilot study Depression. 3:1996;250-256.
42. Mathé A.A., Wikner B.N., Stenfors C., Theodorsson E. Effects of lithium on neuropeptide Y, neurokinin A and substance P in brain and peripheral tissues of rat. Lithium. 5:1994;241-247.
43. Matthews K., Dalley J.W., Matthews C., Tsai T.H., Robbins T. Periodic maternal separation of neonatal rats produces region and gender-specific effects on biogenic amine content in postmortem adult brain. Synapse. 40:2001;1-10.
44. McCauley J., Kern D.E., Kolodner K., Dill L., Schroeder A.F., DeChant H.K., Ryden J., Derogatis L.R., Bass E.B. Clinical characteristics of women with a history of childhood abuse. unhealed wounds JAMA. 277:1997;1362-1368.
45. McKibbin P.E., Cotton S.J., McCarthy H.D., Williams G. The effect of dexamethasone on neuropeptide Y concentrations in specific hypothalamic regions. Life Sci. 51:1992;1301-1307.
46. Meador-Woodruff J.H., Greden J.F. Effects of psychotropic medications on hypothalamic-pituitary-adrenal regulation. Neurol Clin. 6:1988;225-234.
47. Meaney M.J., Aitken D.H., Viau V., Sharma S., Sarrieau A. Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinology. 50:1989;597-604.
48. Overstreet D.H., Rezvani A.H., Janowsky D.S. Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biol Psychiatry. 31:2001;919-936.
49. Plotsky P.M., Meaney M.J. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Brain Res Mol Brain Res. 18:1993;195-200.
50. Plotsky P.M., Sawchenko P.E. Hypophysial-portal plasma levels, median eminence content, and IHC staining of CRF, AVP and OXT after pharmacological adrenalectomy. Endocrinology. 120:1987;1361-1369.
51. Plotsky P.M., Su Y., Keng C., Thrivikraman K.V. Neonatal separation alters HPA axis function, central CRF mRNA levels, behavior and alcohol preference in adult rats. SFN abstracts. 21:1995;500.
52. Rots N.Y., de Jong J., Workel J.O., Levine S., Cools A.R., De Kloet E.R. Neonatal maternally deprived rats have as adults elevated basal pituitary-adrenal activity and enhanced susceptibility to apomorphine. J Neuroendocrinol. 8:1996;501-506.
53. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA. 93:1996;3908-3913.
54. Stenfors C., Theodorsson E., Mathé A.A. Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain. J Neurosci Res. 24:1989;445-450.
55. Stogner K.A., Holmes P.V. Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats. Eur J Pharmacol. 387:2000;R9-10.
56. Suda T., Tozawa F., Iwai I., Sato Y., Sumitomo T., Nakano Y., Yamada M., Demura H. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Brain Res Mol Brain Res. 18:1993;311-315.
57. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - a novel brain peptide with structural similiarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-660.
58. Tatsuoka Y., Riskind P.N., Beal M.F., Martin J.B. The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from rat caudate nucleus. Brain Res. 411:1987;200-203.
59. Tennant C., Hurry J., Bebbington P. The relation of childhood separation experiences to adult depressive and anxiety states. Br J Psychiatry. 141:1982;475-482.
60. Thiele T.E., Marsh D.J., Ste Marie L., Bernstein I.L., Palmiter R.D. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature. 396:1998;366-369.
61. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Rimondini R., Mathé A.A., Heilig M. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA. 97:2000;12852-12857.
62. Tsagarakis S., Rees L.H., Besser G.M., Grossman A. Neuropeptide Y stimulates CRF-41 release from rat hypothalami in vitro. Brain Res. 502:1989;167-170.
63. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1981;1394-1397.
64. Wahlestedt C., Skagerberg G., Ekman R., Heilig M., Sundler F., Håkanson R. Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res. 417:1987;33-38.
65. Westrin A., Ekman R., Traskman-Bendz L. Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt. Eur Neuropsychopharmacol. 9:1999;205-211.
66. Widdowson P.S., Halaris A.E. Increased levels of neuropeptide Y-Immunoreactivity in rat brain limbic structures following antidepressant treatment. J Neurochem. 52:1989;S77.
67. Widerlöv E., Wahlestedt C., Håkanson R., Ekman R. Altered brain neuropeptide function in psychiatric illnesses -with special emphasis on NPY and CRF in major depression. Clin Neuropharmacol. 9:1986;572-574.
68. Zachrisson O., Mathé A.A., Stenfors C., Lindefors N. Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain. Brain Res Mol Brain Res. 31:1995;71-85. a.
69. Zachrisson O., Mathé A.A., Stenfors C., Lindefors N. Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin mRNA expression in the rat brain. Neurosci Lett. 194:1995;89-92. b.
70. Zangen A., Overstreet D.H., Yadid G. Increased catecholamine levels in specific brain regions of a rat model of depression. Normalization by chronic antidepressant treatment Brain Res. 824:1999;243-250.